Haleon (LON:HLN) Stock Price Up 0.4% – Here’s What Happened

Haleon plc (LON:HLN)’s share price traded up 0.4% during mid-day trading on Friday . The company traded as high as GBX 383.50 ($4.84) and last traded at GBX 381.97 ($4.82). 19,355,100 shares changed hands during trading, a decline of 1% from the average session volume of 19,493,533 shares. The stock had previously closed at GBX 380.60 ($4.80).

Haleon Price Performance

The company has a market capitalization of £34.53 billion, a P/E ratio of 3,183.08, a PEG ratio of 1.49 and a beta of 0.19. The company has a debt-to-equity ratio of 54.18, a current ratio of 0.84 and a quick ratio of 0.93. The stock’s fifty day simple moving average is GBX 374.30 and its 200-day simple moving average is GBX 362.40.

Insider Buying and Selling

In other news, insider Alan Stewart acquired 33,923 shares of the business’s stock in a transaction that occurred on Wednesday, November 6th. The stock was acquired at an average price of GBX 368 ($4.64) per share, with a total value of £124,836.64 ($157,562.34). Also, insider Dawn Allen sold 74,679 shares of the stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of GBX 372 ($4.70), for a total transaction of £277,805.88 ($350,632.18). 10.74% of the stock is owned by corporate insiders.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.